Loading…
The collaboration includes an upfront payment, milestones, and royalties.
Rani Therapeutics Holdings, Inc. announced on 2025-10-17 Rani Therapeutics announced a private placement financing of $60.3 million and a collaboration with Chugai Pharmaceutical Co. for up to $1.085 billion.
The announcement cited 60.3 million, 10 million, 75 million, 100 million, 1.085 billion, 18.0 million, 42,633,337 shares, 82,366,667 shares, and 12,500,000 shares. Share consideration (payable in the issuer's shares): 42633337.
Rani Therapeutics Holdings, Inc. has a free float of 74,951,000 shares and 97,541,000 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.